No abstract available
MeSH terms
-
Administration, Oral
-
Cardiovascular Diseases / epidemiology*
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / prevention & control
-
Diabetic Angiopathies / epidemiology*
-
Diabetic Angiopathies / mortality
-
Diabetic Angiopathies / prevention & control
-
Disease Progression
-
Enzyme Inhibitors / therapeutic use
-
Gliclazide / therapeutic use
-
Glycoside Hydrolase Inhibitors
-
Humans
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / therapeutic use*
-
Metformin / therapeutic use
-
Morbidity
-
Predictive Value of Tests
-
Sulfonylurea Compounds / therapeutic use
-
Thiazolidinediones / therapeutic use
Substances
-
Enzyme Inhibitors
-
Glycoside Hydrolase Inhibitors
-
Hypoglycemic Agents
-
Sulfonylurea Compounds
-
Thiazolidinediones
-
Metformin
-
Gliclazide